Table 1:

Summary of treatment mortality.

DFP Model	Treatment	Animal’s Treated	4 hr Post-treatment Mortality (n)	24 hr Post-treatment Mortality (n)	Seizure Termination (n)
	MDZ + PEG200	19	1 (5%)	0	N.E.
	MDZ + 2 mg/kg Retigabine	16	0	0	N.E.
	MDZ + 15 mg/kg Retigabine	21	1 (5%)	1 (5%)	N.E.
	MDZ alone	18	0	0	N.E.
	15 mg/kg Retigabine	19	1 (5%)	0	N.E.
	30 mg/kg Retigabine	7	4 (57%)	3 (43%)	N.E.
Soman Model	Treatment	Animal’s Treated	4 hr Post-treatment Mortality (n)	No Seizure Termination (n)	Seizure Termination (n)
	MDZ + PEG200 @ 20 Min	17	1 (6%)	16 (94%)	0 (0%)
	MDZ + 15 mg/kg Retigabine @ 20 Min	14	8 (57%)	6 (43%)	0 (0%)
	MDZ + 30 mg/kg Retigabine @ 20 Min	12	3 (25%)	1 (8%)	8 (67%)
	30 mg/kg Retigabine @ 20 Min	8	1 (12.5%)	6 (75%)	1 (12.5%)
	60 mg/kg Retigabine @ 20 Min	14	3 (21%)	1 (7%)	10 (71%)
	MDZ + PEG200 @ 40 Min	11	2 (18%)	9 (82%)	0 (0%)
	MDZ + 30 mg/kg Retigabine @ 40 Min	15	3 (20%)	3(20%)	9 (60%)